Amphastar Reports Financial Results For The Three Months And Fiscal Year Ended December 31, 2016 Post author:Sam Post published:March 13, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Jazz Pharma Announces Offering Of $500 Million Of 1.50% Exchangeable Senior Notes Due 2024 August 17, 2017 Aimmune Presents European Phase III PALISADE Screening Data At 2017 European Academy of Allergology and Clinical Immunology (EAACI) Congress June 19, 2017 Daiichi Sankyo Abandons 6 Clinical Programs in Q1 Update May 10, 2017
Jazz Pharma Announces Offering Of $500 Million Of 1.50% Exchangeable Senior Notes Due 2024 August 17, 2017
Aimmune Presents European Phase III PALISADE Screening Data At 2017 European Academy of Allergology and Clinical Immunology (EAACI) Congress June 19, 2017